Press release The Hague, May 10, 2006 AEGON reports 2005 embedded value and value of new business * STRONG INCREASES IN EMBEDDED VALUE AND VALUE OF NEW BUSINESS REFLECT CONTINUED FOCUS ON PROFITABLE GROWTH * VALUE OF NEW BUSINESS INCREASED 13% TO EUR 550 MILLION * TOTAL EMBEDDED VALUE INCREASED 27% TO EUR 21 BILLION * TOTAL EMBEDDED VALUE PER COMMON SHARE INCREASED 27% TO EUR 12.61 * AEGON'S DEVELOPING MARKETS GENERATED 25% OF 2005 VALUE OF NEW BUSINESS The embedded value (EV) and value of new business (VNB) information as reported today by AEGON N.V. demonstrates the increasing diversity of AEGON's business and the continued successful focus on profitable growth. With the strong contribution to value of new business from the developing markets in Asia, Central & Eastern Europe and Other European Countries, AEGON generated a quarter of its VNB outside the three major countries. Joseph B.M. Streppel, Member of the Executive Board and CFO of AEGON N.V., said: "We are pleased with the increases in our embedded value life insurance and value of new business. While not all businesses performed as well as in the prior year, the diversity of AEGON's business and focus on profitable growth continued to drive strong performance. The internal rate of return on new business of over 12% underscores our disciplined approach to writing profitable business." At year-end 2005, the total embedded value (TEV) of AEGON N.V. amounted to EUR 21.0 billion, an increase of 27% compared to 2004. Adjusted for the value of AEGON preferred shares, the total embedded value per common share amounted to EUR 12.61, an increase of 27%. The embedded value life insurance (EVLI) increased 22% to EUR 27.6 billion. The EVLI benefited from the performance of the in-force book of EUR 1.4 billion, higher than expected investment returns of EUR 1.7 billion, and positive currency translation effects of EUR 2.2 billion. The embedded value total margin, which reflects the total change in EVLI excluding capital movements, increased to 25.0% from 12.7% in 2004. The embedded value operating margin, representing the embedded value operating return (value of new business plus in-force performance) divided by beginning of year EVLI, decreased to 7.8% in 2005, primarily reflecting adverse operating variances and assumption changes in the Netherlands, which are partly related to the improvements to Koersplan. All other country units performed in line with expectations. The VNB, reflecting the present value of the projected distributable earnings arising from the sale of new business in 2005, amounted to EUR 550 million, an increase of 13% compared to EUR 489 million reported in 2004. The total internal rate of return on new business in 2005 amounted to 12.4%. AEGON's new operations in the Czech Republic, Poland and Slovakia and partnerships in China, France and Spain have been included in the 2005 EVLI and VNB. In comparative 2004 EV figures, these operations are included at book value under other activities in the TEV figures and were not included in the reported 2004 VNB. AEGON's EVLI and VNB results have been reviewed by Tillinghast. As a result of this review, Tillinghast considers that the methodology adopted, the assumptions used and the results in AEGON's 2005 embedded value report have been properly prepared, are reasonable and comply with the European Embedded Value Principles and Guidance. In giving this opinion, Tillinghast has relied on the values placed on the 'other activities' by AEGON (for more details please refer to section 6 of AEGON's embedded value report). Embedded value Year-end Year-end (amounts in millions unless stated otherwise, after 2005 2004 tax) EUR EUR (A) % Life business Adjusted net worth (ANW) 15,969 12,896 24 Free surplus (FS) 3,184 1,957 63 Required surplus (RS) 12,785 10,939 17 Value of in-force life business (ViF) 11,624 9,748 19 Present value future profits (PVFP) 14,877 12,487 19 Cost of capital (CoC) (3,253) (2,740) 19 Embedded value life insurance (EVLI) 27,593 22,643 22 Other activities IFRS book value 68 665 (90) Total embedded value before holding activities 27,661 23,308 19 Holding activities (6,677) (6,841) (2) Market value of debt, capital securities & (6,433) (6,642) (3) other net liabilities Present value holding expenses (244) (199) 23 Total embedded value (TEV) 20,984 16,467 27 Value of preferred share capital (1,462) (1,601) (9) Total embedded value (TEV) attributable to common 19,522 14,866 31 shareholders TEV attributable to common shareholders per 12.61 9.89 27 share (EUR) (A) Adjusted for the move to IFRS for regulatory accounting in the Netherlands, a required surplus change in Taiwan, the adoption of IFRS in the value of other activities and the presentation of holding debt at market value. Value of new business 2005 2004 % (amounts in millions, after tax) EUR EUR Americas 273 311 (12) The Netherlands 39 29 35 United Kingdom 98 78 26 Asia 83 48 71 Central and Eastern Europe 27 20 33 Other European Countries 30 2 N.M. Total 550 489 13 The tables in this press release provide a summary of AEGON's key 2005 embedded value and value of new business figures. These should be read in conjunction with the detailed information on embedded value life insurance and total embedded value in the report that is available on www.aegon.com. DISCLAIMERS Cautionary note regarding Regulation G (non-GAAP measure) This press release includes a non-GAAP financial measure. Embedded value is not based on IFRS, which are used to prepare and report AEGON's 2005 financial statements and should not be viewed as a substitute for IFRS financial measures. In the 2005 Embedded Value report available on www.aegon.com, the embedded value life insurance and the total embedded value are reconciled to shareholders' equity of EUR 19.3 billion as reported in AEGON's annual accounts over the year 2005. AEGON believes the non-GAAP measure shown herein, together with the GAAP information, provides a meaningful measure for the investment community to evaluate AEGON's business relative to the businesses of our peers. Forward looking statements The statements contained in this press release that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as believe', estimate', intend', may', expect', anticipate', predict', project', counting on', plan', continue', want', forecast', should', would', is confident' and will' and similar expressions as they relate to us are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. We undertake no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations, including, but not limited to, the following: * Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom; * Changes in the performance of financial markets, including emerging markets, including: - The frequency and severity of defaults by issuers in our fixed income investment portfolios; and - The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in value of equity and debt securities we hold; * The frequency and severity of insured loss events; * Changes affecting mortality, morbidity and other factors that may affect the profitability of our insurance products; * Changes affecting interest rate levels and continuing low interest rate levels and rapidly changing interest rate levels; * Changes affecting currency exchange rates, including the EUR/USD and EUR/GBP exchange rates; * Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; * Changes in laws and regulations, particularly those affecting our operations, the products we sell and the attractiveness of certain products to our consumers; * Regulatory changes relating to the insurance industry in the jurisdictions in which we operate; * Acts of God, acts of terrorism, acts of war and pandemics; * Changes in the policies of central banks and/or governments; * Litigation or regulatory action that could require us to pay significant damages or change the way we do business; * Customer responsiveness to both new products and distribution channels; * Competitive, legal, regulatory, or tax changes that affect the distribution cost of or demand for our products; * Our failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives; * The impact on our reported financial results and financial condition as a result of our adoption of International Financial Reporting Standards. ABOUT AEGON AEGON is one of the world's largest life insurance and pension companies, and a strong provider of investment products. We empower our local business units to identify and provide products and services that meet the evolving needs of our customers, using distribution channels best suited to their local markets. We take pride in balancing a local approach with the power of an expanding global operation. With headquarters in The Hague, the Netherlands, AEGON companies employ approximately 27,000 people. AEGON's three major markets are the United States, the Netherlands and the United Kingdom. In addition, the Group is present in a number of other countries including Canada, China, Czech Republic, Hungary, Poland, Slovakia, Spain and Taiwan. Respect, quality, transparency and trust constitute AEGON's core values as the company continually strives to meet the expectations of customers, shareholders, employees and business partners. AEGON is driven to deliver new thinking and our ambition is to be the best in the industry. CONTACT INFORMATION Group Corporate Affairs & Investor Relations The Hague, the Baltimore, the United States Netherlands Analysts & +31 (0)70 344 83 05 +1 877 548 9668 (toll free) / +1 Investors 410 576 45 77 Media +31 (0)70 344 83 44 +1 410 576 45 26 E-mail gca-ir@aegon.com ir@aegonusa.com Website www.aegon.com END